Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
Advances in Neurology|January 1, 1984
A new selective suicide inhibitor of peripheral DOPA decarboxylaseJ Wajsbort, M B Youdim
Neurochemistry International|May 27, 2010
MPTP induced dopaminergic neurotoxicity-a useful model in the study of parkinson's disease?P Riederer, M B Youdim
Pharmacological Research Communications|December 1, 1988
Monoamine oxidase B; a misunderstood and misjudged enzymeM B Youdim, P Riederer
Advances in Biochemical Psychopharmacology|January 1, 1977
Are there MAO inhibitors specific for dopamine metabolism?M B Youdim, M Holzbauer
Journal of Neural Transmission|January 1, 1975
The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgylineM B Youdim, B Holman
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 29, 2000
The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate systemM B Youdim, S Yehuda
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 30, 2000
Iron involvement in neural damage and microgliosis in models of neurodegenerative diseasesS Shoham, M B Youdim
Journal of Neural Transmission. Supplementum|January 1, 1993
The role of iron in senescence of dopaminergic neurons in Parkinson's diseaseM B Youdim, P Riederer
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1983
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluationJ Mendlewicz, M B Youdim
Journal of Affective Disorders|June 1, 1980
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illnessJ Mendlewicz, M B Youdim
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Advances in Neurology|January 1, 1984
A new selective suicide inhibitor of peripheral DOPA decarboxylaseJ Wajsbort, M B Youdim
Neurochemistry International|May 27, 2010
MPTP induced dopaminergic neurotoxicity-a useful model in the study of parkinson's disease?P Riederer, M B Youdim
Pharmacological Research Communications|December 1, 1988
Monoamine oxidase B; a misunderstood and misjudged enzymeM B Youdim, P Riederer
Advances in Biochemical Psychopharmacology|January 1, 1977
Are there MAO inhibitors specific for dopamine metabolism?M B Youdim, M Holzbauer
Journal of Neural Transmission|January 1, 1975
The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgylineM B Youdim, B Holman
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 29, 2000
The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate systemM B Youdim, S Yehuda
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 30, 2000
Iron involvement in neural damage and microgliosis in models of neurodegenerative diseasesS Shoham, M B Youdim
Journal of Neural Transmission. Supplementum|January 1, 1993
The role of iron in senescence of dopaminergic neurons in Parkinson's diseaseM B Youdim, P Riederer
The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1983
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluationJ Mendlewicz, M B Youdim
Journal of Affective Disorders|June 1, 1980
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illnessJ Mendlewicz, M B Youdim
Pageof 35